Innovative Industrial Properties (IIPR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Achieved $308.5 million in revenue and $256.1 million in AFFO for 2024, with a 74% and 95% CAGR since 2017, respectively.
Returned over $211 million to shareholders via dividends, maintaining a 45% annual dividend CAGR since 2017.
Maintained a low leverage profile with 11% debt to total gross assets and $238.7 million in liquidity as of year-end 2024.
Upsized revolving credit facility to $87.5 million in 2024.
Focused on employee well-being, community investment, and property upgrades for efficiency and sustainability.
Voting matters and shareholder proposals
Election of five directors to serve until the 2026 annual meeting.
Ratification of BDO USA, P.C. as independent auditor for 2025.
Advisory vote on executive compensation (say-on-pay).
Shareholders may submit proposals for the 2026 meeting by December 30, 2025.
Board of directors and corporate governance
Board reduced from six to five members due to retirements; three of five nominees are independent.
All directors subject to annual election; majority are independent.
Board committees (audit, compensation, nominating/governance) are fully independent.
Annual self-evaluations, orientation, and continuing education for directors.
Stock ownership requirements, code of ethics, anti-hedging/pledging, and clawback policies in place.
No stockholder rights plan; bylaws allow shareholder amendments.
Latest events from Innovative Industrial Properties
- 2025 revenues hit $266M; life sciences investment and leasing drive growth amid tenant challenges.IIPR
Q4 202524 Feb 2026 - Q2 revenue up 4% to $79.8M, AFFO $2.29/share, 95.6% leased, and dividend up 4.4%.IIPR
Q2 20242 Feb 2026 - Q3 2024 revenue was $76.5M, AFFO $64.3M, and portfolio was 95.7% leased.IIPR
Q3 202415 Jan 2026 - 2024 revenue steady at $308.5M; strong liquidity, high occupancy, and PharmaCann lease resolution.IIPR
Q4 202423 Dec 2025 - Annual meeting to vote on directors, auditor, and executive pay, with board support for all.IIPR
Proxy Filing1 Dec 2025 - Q1 2025 revenue and net income fell on tenant defaults, but liquidity and leasing remain strong.IIPR
Q1 202524 Nov 2025 - Q2 2025 revenue and AFFO fell sharply, but liquidity is strong and IQHQ investment boosts outlook.IIPR
Q2 202523 Nov 2025 - Q3 2025 revenue fell 15% to $64.7M as tenant defaults hit, but life sciences diversification advanced.IIPR
Q3 202513 Nov 2025 - Diversified cannabis real estate portfolio drives growth and strong shareholder returns.IIPR
Investor Presentation14 Oct 2025